Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,617 | 21,738 | 11,315 | 8,293 | 9,555 |
| Receivables | 40,872 | 36,219 | 29,207 | 18,454 | 21,444 |
| Inventories | 18,165 | 19,357 | 16,240 | 20,158 | 14,165 |
| TOTAL | $85,794 | $77,861 | $57,739 | $48,050 | $45,294 |
| Non-Current Assets | |||||
| PPE Net | 10,098 | 10,270 | 10,327 | 9,864 | 10,177 |
| Intangibles | 5,638 | 5,638 | 5,638 | 7,241 | 7,241 |
| Other Non-Current Assets | 15,718 | 17,571 | 22,683 | 25,602 | 25,486 |
| TOTAL | $31,454 | $33,478 | $38,648 | $42,707 | $42,904 |
| Total Assets | $117,248 | $111,339 | $96,388 | $90,757 | $88,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 231 | 231 | 4,247 | 4,290 | 4,368 |
| Accounts payable and accrued liabilities | 3,425 | 5,089 | 2,958 | 5,840 | 1,983 |
| Accrued Expenses | 6,152 | 4,582 | 3,795 | 3,719 | 5,704 |
| TOTAL | $10,674 | $10,763 | $11,840 | $14,689 | $12,854 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,845 | 3,014 | 3,033 | 3,052 | 3,076 |
| Deferred Revenues | N/A | 2 | 6 | 9 | 12 |
| Other Non-Current Liabilities | 41,082 | 48,733 | 26,751 | 35,242 | 23,577 |
| TOTAL | $44,989 | $52,894 | $31,032 | $39,622 | $28,077 |
| Total Liabilities | $55,663 | $63,657 | $42,873 | $54,311 | $40,931 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,074,496 | 1,070,963 | 1,068,463 | 1,068,273 | 1,068,273 |
| Common Shares | 1,074 | 1,069 | 1,069 | 1,068 | 1,068 |
| Retained earnings | -112,886 | -126,589 | -120,704 | -137,702 | -126,810 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $61,585 | $47,683 | $53,515 | $36,446 | $47,267 |
| Total Liabilities And Equity | $117,248 | $111,339 | $96,388 | $90,757 | $88,198 |